GoodRx Holdings, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| GoodRx Holdings, Inc. | GDRX - NASDAQ |
$24.00-$28.00 | $33.00 | $46.00 | 34.6 million | 9/23/2020 |
| Morgan Stanley, Goldman Sachs, J.P. Morgan, Barclays, BofA Securities, Citigroup, Credit Suisse, RBC Capital Markets, UBS Investment Bank, Cowen, Deutsche Bank Securities, Evercore ISI | ||||||
Co-Manager(s): Citizens Capital Markets, KKR, LionTree, Raymond James, SVB Leerink, Academy Securities, Loop Capital Markets, R. Seelaus & Co., Ramirez & Co. | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-08-28 Terms Added 2020-09-14 | ||||||
GoodRx Holdings, Inc. Quote & Chart - Click for current quote - GDRX
IPO Boutique aggregates information on public companies and private companies, such as "GDRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About GoodRx Holdings, Inc. (adapted from GoodRx Holdings, Inc. prospectus):
They are building the leading, consumer-focused digital healthcare platform in the United States.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are building the leading, consumer-focused digital healthcare platform in the United States.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "GDRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.